Literature DB >> 21047732

Regulation of cell cycle genes and induction of senescence by overexpression of OTX2 in medulloblastoma cell lines.

Jens Bunt1, Talitha G de Haas, Nancy E Hasselt, Danny A Zwijnenburg, Jan Koster, Rogier Versteeg, Marcel Kool.   

Abstract

The transcription factor orthodenticle homeobox 2 (OTX2) has been implicated in the pathogenesis of medulloblastoma, as it is often highly expressed and sometimes amplified in these tumors. Little is known of the downstream pathways regulated by OTX2. We therefore generated MED8A and DAOY medulloblastoma cell lines with doxycycline-inducible OTX2 expression. In both cell lines, OTX2 inhibited proliferation and induced a senescence-like phenotype with senescence-associated β-galactosidase activity. Expression profiles of time series after OTX2 induction in MED8A showed early upregulation of cell cycle genes related to the G(2)-M phase, such as AURKA, CDC25C, and CCNG2. Paradoxically, G(1)-S phase genes such as MYC, CDK4, CDK6, CCND1, and CCND2 were strongly downregulated, in line with the observed G(1) arrest. ChIP-on-chip analyses of OTX2 binding to promoter regions in MED8A and DAOY showed a strong enrichment for binding to the G(2)-M genes, suggesting a direct activation. Their mRNA expression correlated with OTX2 expression in primary tumors, underscoring the in vivo relevance of this regulation. OTX2 induction activated the P53 pathway in MED8A, but not in DAOY, which carries a mutated P53 gene. In DAOY cells, senescence-associated secretory factors, such as interleukin-6 and insulin-like growth factor binding protein 7, were strongly upregulated after OTX2 induction. We hypothesize that the imbalance in cell cycle stimulation by OTX2 leads to cellular senescence either by activating the P53 pathway or through the induction of secretory factors. Our data indicate that OTX2 directly induces a series of cell cycle genes but requires cooperating genes for an oncogenic acceleration of the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21047732     DOI: 10.1158/1541-7786.MCR-09-0546

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  23 in total

1.  Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.

Authors:  Shyamal Dilhan Weeraratne; Vladimir Amani; Natalia Teider; Jessica Pierre-Francois; Dominic Winter; Min Jeong Kye; Soma Sengupta; Tenley Archer; Marc Remke; Alfa H C Bai; Peter Warren; Stefan M Pfister; Judith A J Steen; Scott L Pomeroy; Yoon-Jae Cho
Journal:  Acta Neuropathol       Date:  2012-03-10       Impact factor: 17.088

2.  Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.

Authors:  Kok-Siong Chen; Caitlin R Bridges; Zorana Lynton; Jonathan W C Lim; Brett W Stringer; Revathi Rajagopal; Kum-Thong Wong; Dharmendra Ganesan; Hany Ariffin; Bryan W Day; Linda J Richards; Jens Bunt
Journal:  J Neurooncol       Date:  2019-11-23       Impact factor: 4.130

Review 3.  OTX2 expression contributes to proliferation and progression in Myc-amplified medulloblastoma.

Authors:  Yining Lu; Collin M Labak; Neha Jain; Ian J Purvis; Maheedhara R Guda; Sarah E Bach; Andrew J Tsung; Swapna Asuthkar; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 4.  A contemporary review of molecular candidates for the development and treatment of childhood medulloblastoma.

Authors:  N Ceren Sümer-Turanlıgil; Emel Öykü Cetin; Yiğit Uyanıkgil
Journal:  Childs Nerv Syst       Date:  2013-01-06       Impact factor: 1.475

5.  HDM2 promotes WIP1-mediated medulloblastoma growth.

Authors:  Meghan C Buss; Tracy-Ann Read; Matthew J Schniederjan; Khanjan Gandhi; Robert C Castellino
Journal:  Neuro Oncol       Date:  2012-02-29       Impact factor: 12.300

6.  Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model.

Authors:  Michelle J Lee; Beryl A Hatton; Elisabeth H Villavicencio; Paritosh C Khanna; Seth D Friedman; Sally Ditzler; Barbara Pullar; Keith Robison; Kerry F White; Chris Tunkey; Michael LeBlanc; Julie Randolph-Habecker; Sue E Knoblaugh; Stacey Hansen; Andrew Richards; Brandon J Wainwright; Karen McGovern; James M Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

7.  OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells.

Authors:  Ren-Yuan Bai; Verena Staedtke; Hart G Lidov; Charles G Eberhart; Gregory J Riggins
Journal:  Cancer Res       Date:  2012-09-17       Impact factor: 12.701

8.  DRAXIN regulates interhemispheric fissure remodelling to influence the extent of corpus callosum formation.

Authors:  Laura Morcom; Timothy J Edwards; Eric Rider; Dorothy Jones-Davis; Jonathan Wc Lim; Kok-Siong Chen; Ryan J Dean; Jens Bunt; Yunan Ye; Ilan Gobius; Rodrigo Suárez; Simone Mandelstam; Elliott H Sherr; Linda J Richards
Journal:  Elife       Date:  2021-05-04       Impact factor: 8.713

9.  Joint binding of OTX2 and MYC in promotor regions is associated with high gene expression in medulloblastoma.

Authors:  Jens Bunt; Nancy E Hasselt; Danny A Zwijnenburg; Jan Koster; Rogier Versteeg; Marcel Kool
Journal:  PLoS One       Date:  2011-10-10       Impact factor: 3.240

10.  Expression of p53 in the effects of artesunate on induction of apoptosis and inhibition of proliferation in rat primary hepatic stellate cells.

Authors:  Peng Longxi; Fang Buwu; Wang Yuan; Gao Sinan
Journal:  PLoS One       Date:  2011-10-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.